Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Peter Gregersen, North Shore Long Island Jewish Health System

ClinicalTrials.gov Identifier:

NCT00926042

First received: June 19, 2009

Last updated: January 23, 2013

Last verified: January 2013

History of Changes

Purpose

Registry program for volunteers who are willing to serve as control subjects in future research studies.

Condition
Healthy

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	TAP0307: Enrollment of Normal Control Subjects for Current and Future Research

Further study details as provided by North Shore Long Island Jewish Health System:

Biospecimen Retention: Samples With DNA

Cheek cell DNA sample will be collected

Enrollment:	4511
Study Start Date:	February 2004
Study Completion Date:	August 2012
Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)

Detailed Description:

The registry is a collection of volunteers willing to participate as control subjects in research studies. Control subjects are people who do not have a specific disease; therefore they can serve a critical role as a comparison with people who have the disease or other characteristic being studied. Once registered, participants will be notified about studies they may be able to participate in as a control.

Participation requires:

signing a consent form
answering a short health survey
providing a DNA sample via a mouthwash kit

The registry allows scientists to select study participants based on whether or not they have a specific genetic change that may be relevant to a disease under investigation. Having the ability to access controls when needed is an extremely valuable resource that will speed up scientific discoveries.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

New York City/ Long Island metropolitan community

Criteria

Inclusion Criteria:

Generally healthy
over age 18

Exclusion Criteria:

under age 18

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00926042

Locations

United States, New York
The Feinstein Institute for Medical Research
Manhasset, New York, United States, 11030

Sponsors and Collaborators

North Shore Long Island Jewish Health System

Investigators

Principal Investigator:

Peter K Gregersen, MD

North Shore Long Island Jewish Health System

More Information

No publications provided

Responsible Party:	Peter Gregersen, Center Head, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:	NCT00926042 History of Changes
Other Study ID Numbers:	04-007
Study First Received:	June 19, 2009
Last Updated:	January 23, 2013
Health Authority:	United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:

Healthy
volunteer
Healthy controls
Normal controls

ClinicalTrials.gov processed this record on May 23, 2013

To Top